150
Participants
Start Date
April 4, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
November 30, 2026
Placebo
Oral dose, once a day for 24 weeks
DISC-1459
Oral dose, once a day for 24 weeks
RECRUITING
Royal Prince Alfred Hospital, Camperdown
RECRUITING
The Royal Melbourne Hospital, Parkville
RECRUITING
Mount Sinai Hospital, New York
RECRUITING
Wake Forest University, Winston-Salem
RECRUITING
University of Miami Miller School of Medicine, Miami
RECRUITING
Remington-Davis Clinical Research, Columbus
NOT_YET_RECRUITING
The Cleveland Clinic, Cleveland
RECRUITING
Henry Ford Health System, Detroit
RECRUITING
University of Texas Medical Branch, Galveston
RECRUITING
Marvel Clinical Research, Huntington Beach
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
University of Washington, Seattle
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
MetroBoston Clinical Partners, Boston
NOT_YET_RECRUITING
University of Alberta, Edmonton
Lead Sponsor
Disc Medicine, Inc
INDUSTRY